UPDATE: Goldman Sachs Starts Apria Inc (APR) at Buy

Goldman Sachs analyst Jamie Perse initiates coverage on Apria Inc (NASDAQ: APR) with a Buy rating and a price target of $30.00.

The analyst comments "Apria is a leading distributor of home durable medical equipment focused mostly on Respiratory and Sleep Apnea end-markets. The company is positioned to compete effectively in its targeted $10B+ combined core markets owing to its broad footprint across the US (where Apria has the ability to reach 90% of the US population),
robust payor coverage, and an improved operating structure position."

For an analyst ratings summary and ratings history on Apria Inc click here. For more ratings news on Apria Inc click here.

Shares of Apria Inc closed at $21.59 yesterday.

You May Also Be Interested In

• UPDATE: Goldman Sachs Starts Iovanace Biotherapeutics (IOVA) at Buy
• Localiza Rent a Car S.A. (RENT3:BZ) (LZRFY) PT Lowered to R$67 at Morgan Stanley
• Siemens AG (SIE:GR) (SIEGY) PT Raised to EUR170 at Jefferies